California v. Infineon Technologies, No. 3:06-cv-04333 (N.D. Cal. Nov. 7, 2007)
33 Plaintiff States generally alleged a horizontal price-fixing conspiracy in the U.S.
market for dynamic random access memory (“DRAM”), carried out by numerous manufacturer defendants. Samsung an
another company, Winbond, reached settlement for $113 million in 2007.. States and private parties settled with the remaining defendants for $173 million and injunctive relief.
U.S. and Minnesota v. Alltel Corp. et al.06-3631 (RHK/AJB) (D. Minn. 2007)
Alltel Corp. paid $1.3 million to the United States and Minnesota to settle allegations that it violated conditions of its acquisition of Midwest Wireless. Alltel had agreed to maintain the Midwest Wireless assets while it finished the acquisition, so it could divest its service in several rural Minnesota counties because of antitrust concerns. Minnesota and US DOJ accused Alltel of failing to maintain those assets as agreed. The state got $745,000 from the settlement, and the Justice Department got $580,000,
Connecticut v. Leviton Manufacturing Co., Inc., et al. (In re: Electrical Wiring Devices Antitrust Litigation)No. H-79-64 (D. Conn. 1978)
Various manufacturers of electrical wiring devices settled Attorney General’s claims of price fixing via entry of consent decree prohibiting such conduct and payment of monetary forfeiture. Parallel USDOJ criminal case
Massachusetts v. First Group, PLC
Eleven states alleged that the merger would substantially lessen competition in numerous markets for the procurement of School Bus Services within the Plaintiff States. Settlement required divestitures of routes and depots, provision o fmaintenance services, no non-compete agreements, notice to the states of future acquisitions, and no coercion to include certain bid specifications plus $1.1 million in attorneys fees.
New York v. Tele-Communications Inc., 1993 WL 527984 (S.D.N.Y. Sept. 14, 1993), 1993-2 Trade Cases P 70, 404
Defendant cable system operators, subsidiaries and a satellite cable supplier formed a monopoly in restraint of trade in the delivery of multichannel subscription television programming.
In the Matter of GlaxoSmithKline, PLC (Augmentin)
States alleged that GlaxoSmithKline fraudulently obtained patent protection for Augmentin and then delayed generic entry through sham patent litigation. Through this conduct, GlaxoSmithKline unlawfully maintained its monopoly over Augmentin. A $3.5 million multistate settlement for state proprietary claims was entered into by the participating states and GlaxoSmithKline.
In Re Relafen Antitrust Litigation
States sued manufacturer of antidepressant Relafen, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled the state proprietary claims for $10 million.
Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)
States sued manufacturer of antitdepressant Paxil, alleging patent misuse and sham litigation designed to prevent generic entry. Parties settled for $14 million.
In the Matter of Tri-County Hospital and Wadena Med. Center, No. C4-94-11900 (Ramsey Cty. Cr. Minn., Nov. 30, 1994)
State alleged hospital and large clinic sought to allocate the markets for x-ray equipment and colposcopy equipment.
U.S. and Texas, et al v. Oracle, Corporation, No.C-04 0807 (JCS )(N.D.Cal.2005)
Merger review of two of the most dominant vendors of high function Human Resource Management software and high function Financial Management Services software.
